David Mounts Gonzales exits ModivCare board; stock on Expert Market

Rhea-AI Filing Summary

ModivCare Inc. announced that director David Mounts Gonzales resigned from its Board, effective November 9, 2025. The company stated his departure was not due to any disagreement regarding operations, policies, or practices.

As trading context, at the opening of business on August 28, 2025, the company’s common stock was suspended from Nasdaq and began being quoted on the Expert Market operated by OTC Markets Group under the symbol MODVQ. Nasdaq filed a Form 25‑NSE on October 1, 2025 to delist the common stock and remove it from registration under Section 12(b).

Insights

Corporate governance analyst

Single director resignation disclosed; no disagreement indicated.

ModivCare reported the immediate resignation of director David Mounts Gonzales on November 9, 2025. The filing explicitly states the resignation was not due to any disagreement on operations, policies, or practices, which typically signals an administrative board change rather than a strategic dispute.

The company also notes prior listing status changes: trading suspension on August 28, 2025, quotation on the Expert Market as MODVQ, and a Form 25‑NSE filed on October 1, 2025. Market impact from the resignation alone is usually limited; actual effects depend on subsequent board composition and disclosures.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Understanding 8-K Material Events →

0001220754FALSE00012207542025-11-092025-11-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 9, 2025

ModivCare Inc.

(Exact name of registrant as specified in its charter)

Delaware			001-34221			86-0845127
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

6900 E. Layton Avenue,

12th Floor

Denver,

Colorado

80237

(Address of principal executive offices)

(Zip Code)

(720) 258-2130

Registrant’s telephone number, including area code:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of exchange on which registered
Common Stock, $0.001 par value per share			MODVQ*			OTC Markets Group*

* At the opening of business on August 28, 2025, the registrant’s common stock was suspended from trading on The Nasdaq Global Select Market and trades in the registrant’s common stock began being quoted on the Expert Market operated by the OTC Markets Group under the symbol “MODVQ”. The Nasdaq Stock Market LLC filed a Form 25-NSE on October 1, 2025 to delist the registrant’s common stock and to remove it from registration under Section 12(b) of the U.S. Securities Exchange Act of 1934, as amended. 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company			☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.			☐

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Directors; Compensatory Arrangements of Certain Officers.

On November 9, 2025, David Mounts Gonzales resigned from the Board of Directors of ModivCare Inc. (the “Company”), effective immediately. His resignation was not a result of any disagreement with the Company on any matter relating to its operations, policies or practices.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ModivCare Inc.

Date: November 12, 2025

By:

/s/ Faisal Khan

Name:

Faisal Khan

Title:

Senior Vice President, General Counsel and Secretary

 

FAQ

What did ModivCare (MODV) announce in this 8-K?

The company disclosed that director David Mounts Gonzales resigned effective November 9, 2025.

Did ModivCare state a disagreement related to the resignation?

No. The company stated the resignation was not due to any disagreement on operations, policies, or practices.

Where does ModivCare’s stock trade now and under what symbol?

Shares are quoted on the Expert Market operated by OTC Markets Group under the symbol MODVQ.

What happened to ModivCare’s Nasdaq listing?

At the opening of business on August 28, 2025 trading was suspended; Nasdaq filed Form 25‑NSE on October 1, 2025 to delist and remove Section 12(b) registration.

Who signed the report for ModivCare?

It was signed by Faisal Khan, Senior Vice President, General Counsel and Secretary.